Latest SENS Announcements

View All SensBack To Instrument
Dealing in securities by the company secretary
e497a6ff-c543-4d97-a9a3-d8a9e71666d4
S469936 -
Download
Acceptance of awards by the executive directors, prescribed officers and the company secretary
ac62a5f5-dc50-403e-b11e-3944a43f5b85
S469538 -
Download
Dealings in securities by executive directors, prescribed officers and the company secretary
c343798f-555d-4fb6-bbbd-1975d7726e82
S469511 -
Download
Dealing in securities by a director
b71c4623-e276-4823-a9a5-501fa421110b
S469245 -
Download
Report on proceedings at the annual general meeting
5b8195fc-2d73-4b17-a71d-a4eec444764d
S469197 -
Download
Dealing in securities by the company secretary
dc9201c3-740c-4c1d-ba7b-31da74de7d7b
S469087 -
Download
No change statement and notice of annual general meeting
7522e97e-84cc-4158-81b2-47be3475a22a
S467699 -
Download
Distribution of shareholding in Grindrod, cash proceeds of fractional entitlements and apportionment of tax cost
f6e5f11e-2276-41d7-9499-8b15933b06b0
S467007 -
Download
Availability of Broad-Based Black Economic Empowerment Compliance report
1b2611f9-2b45-4beb-92fb-f581fab9a1fc
S466510 -
Download
Summary of audited results for the year ended 30 June 2022 and cash dividend declaration
daa37dcf-064c-4646-a9da-ad55a13e371e
S466239 -
Download
Declaration and finalisation announcement regarding the distribution of Grindrod shares to Remgro shareholders
38dc46d2-2ba4-4fc0-b828-6204b3728695
S466238 -
Download
Trading statement for the year ended 30 June 2022
b6f2b20f-9b6e-4021-ae52-2c37aa337b1b
S465868 -
Download
Dealing in securities by a prescribed officer
66b7b130-8b3e-4d91-ae32-e3e1b27943a9
S465673 -
Download
Category 2 acquisition announcement
d467c8cb-6a14-49bd-9960-a134c16068a3
S464158 -
Download
Mediclinic International Plc (“Mediclinic) Offer Update – Extension to PUSU deadline
a8507879-d304-412b-a62b-85a3c4a21dde
S463136 -
Download
Remgro Capital Markets Day (“CMD”) presentation
66146a32-152c-44a3-b3a9-ae97fbef0ef7
S462133 -
Download
Response to press speculation on Mediclinic International plc (“Mediclinic”)
cd331a8c-696f-4bd3-a022-6a54a66ff916
S461969 -
Download
Dealing in securities by an associate of a company secretary of a major subsidiary
0650e8bd-0fbc-4105-8170-6aafc63b917c
S460739 -
Download
Change in function of a director
9e9b6245-408b-4da8-be02-0de20f2a0dca
S458924 -
Download
Summary of unaudited results for the six months ended 31 December 2021 and cash dividend declaration
2c231d0e-817e-41da-8206-2a51b90aee8f
S458907 -
Download